Home / News / FAQ
FAQ

FAQ on SOBRsafe Inc.'s European Patent for SOBRcheck Alcohol Detection Device

FaqStaq News - Just the FAQs • August 7, 2025
By FAQstaq Staff
Read Original Article →
FAQ on SOBRsafe Inc.'s European Patent for SOBRcheck Alcohol Detection Device

Summary

SOBRsafe Inc. has been granted a European patent for its SOBRcheck device, a noninvasive alcohol detection system, enhancing its market position in safety and compliance sectors ahead of European pilot programs in 2025.

What is the SOBRcheck device?

The SOBRcheck device is a noninvasive transdermal alcohol screening system developed by SOBRsafe Inc. that uses skin-contact verification, biometric ID scanning, and wireless data transmission to detect alcohol consumption without the need for breath, blood, or urine samples.

Why is the European patent for SOBRcheck significant?

The European patent strengthens SOBRsafe’s position in the workplace safety, judicial compliance, and wellness markets in Europe, providing legal protection for its proprietary technology ahead of planned pilot programs in the second half of 2025.

How does the SOBRcheck device work?

SOBRcheck detects and reports in real-time the presence of alcohol as emitted through a user’s skin, utilizing advanced transdermal technology without requiring intrusive sampling methods.

Who can benefit from the SOBRcheck device?

The device is designed for use in behavioral health, family law, consumer markets, and for licensing and integration, offering passive, dignified screening and monitoring solutions.

When are the European pilot programs for SOBRcheck expected to begin?

The European pilot programs for SOBRcheck are planned to commence in the second half of 2025.

Where can I find more information about SOBRsafe and the SOBRcheck device?

More information is available on SOBRsafe’s website at www.sobrsafe.com and in the company’s newsroom at https://ibn.fm/SOBR.

What are the implications of this patent for SOBRsafe?

The patent provides SOBRsafe with intellectual property protection in Europe, enhancing its competitive edge and market potential in safety and compliance sectors.

How does SOBRcheck compare to traditional alcohol detection methods?

Unlike traditional methods that require breath, blood, or urine samples, SOBRcheck offers a noninvasive, touch-based solution that is more dignified and less intrusive for users.

What should investors know about this development?

Investors should note that this patent represents a significant milestone for SOBRsafe, potentially opening up new markets and opportunities in Europe, with updates available in the company’s newsroom at https://ibn.fm/SOBR.

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)

Article Control ID: 139870